Somerset Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.12M | Buy |
8,701
+81
| +0.9% | +$9.48K | 0.32% | 68 |
|
|
2026
Q1 | $1.04M | Buy |
8,620
+3
| +0% | +$346 | 0.32% | 67 |
|
|
2025
Q4 | $907K | Buy |
8,617
+368
| +4% | +$34.5K | 0.28% | 68 |
|
|
2025
Q3 | $692K | Sell |
8,249
-2,331
| -22% | -$192K | 0.21% | 79 |
|
|
2025
Q2 | $838K | Buy |
10,580
+133
| +1% | +$10.6K | 0.27% | 67 |
|
|
2025
Q1 | $938K | Buy |
10,447
+2,054
| +24% | +$192K | 0.33% | 61 |
|
|
2024
Q4 | $835K | Buy |
8,393
+595
| +8% | +$61.3K | 0.31% | 60 |
|
|
2024
Q3 | $886K | Buy |
7,798
+1,375
| +21% | +$163K | 0.33% | 62 |
|
|
2024
Q2 | $795K | Buy |
6,423
+210
| +3% | +$27.1K | 0.33% | 60 |
|
|
2024
Q1 | $820K | Buy |
6,213
+641
| +12% | +$79K | 0.33% | 58 |
|
|
2023
Q4 | $607K | Buy |
5,572
+1,146
| +26% | +$119K | 0.27% | 68 |
|
|
2023
Q3 | $456K | Sell |
4,426
-293
| -6% | -$31.6K | 0.21% | 82 |
|
|
2023
Q2 | $545K | Sell |
4,719
-453
| -9% | -$51.4K | 0.23% | 72 |
|
|
2023
Q1 | $550K | Sell |
5,172
-1,029
| -17% | -$111K | 0.24% | 71 |
|
|
2022
Q4 | $688K | Buy |
6,201
+740
| +14% | +$75.6K | 0.29% | 67 |
|
|
2022
Q3 | $470K | Buy |
5,461
+47
| +0.9% | +$4.2K | 0.22% | 73 |
|
|
2022
Q2 | $494K | Buy |
5,414
+245
| +5% | +$21.7K | 0.22% | 73 |
|
|
2022
Q1 | $424K | Buy |
5,169
+294
| +6% | +$23.2K | 0.16% | 90 |
|
|
2021
Q4 | $374K | Buy |
4,875
+78
| +2% | +$6.21K | 0.14% | 98 |
|
|
2021
Q3 | $360K | Buy |
+4,797
| New | +$365K | 0.15% | 96 |
|
|
2019
Q2 | – | Sell |
-733
| Closed | -$58K | – | 146 |
|
|
2019
Q1 | $58K | Buy |
733
+555
| +312% | +$41.5K | 0.03% | 115 |
|
|
2018
Q4 | $13K | Buy |
178
+153
| +612% | +$10.8K | 0.01% | 140 |
|
|
2018
Q3 | $2K | Buy |
+25
| New | +$1.59K | ﹤0.01% | 151 |
|
|
2017
Q2 | – | Sell |
-57
| Closed | -$3K | – | 164 |
|
|
2017
Q1 | $3K | Buy |
+57
| New | +$3.46K | ﹤0.01% | 176 |
|
|
2015
Q2 | – | Sell |
-1,142
| Closed | -$63K | – | 177 |
|
|
2015
Q1 | $63K | Hold |
1,142
| – | – | 0.04% | 138 |
|
|
2014
Q4 | $62K | Hold |
1,142
| – | – | 0.04% | 133 |
|
|
2014
Q3 | $65K | Hold |
1,142
| – | – | 0.05% | 133 |
|
|
2014
Q2 | $63K | Hold |
1,142
| – | – | 0.04% | 132 |
|
|
2014
Q1 | $62K | Hold |
1,142
| – | – | 0.05% | 134 |
|
|
2013
Q4 | $55K | Buy |
+1,142
| New | +$52.2K | 0.04% | 134 |
|
Other funds holding MRK
ECSS
Somerset Trust's MRK Position: Q2 2026 in Review
Somerset Trust increased its Merck (MRK) stake by 0.94% in Q2 2026, buying an estimated $9.48K and bringing the position to 8,701 shares worth $1.12M. The position accounts for 0.32% of the portfolio, ranked #68.
Somerset Trust first reported a position in MRK in Q4 2013 and has held it in 30 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Somerset Trust held 8,701 shares of Merck worth $1.12M as of Q2 2026.
- Somerset Trust bought 81 Merck shares in Q2 2026, an estimated $9.48K.
- Merck made up 0.32% of Somerset Trust's portfolio in Q2 2026, its #68 holding.
- Somerset Trust first reported a position in Merck in Q4 2013 and has held it in 30 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.